Biotech company Novoheart has created the world ’s first miniature artificial heart using stem cells , with the goal of offering pharmaceutical testing methods which are more efficient than animal models and clinical trials . The company said its “ heart in a miniature ” saves costs and time . The device replicates one of the human heart ’s four chambers but does not need a blood supply . At the same time , its MyHeart platform offers technology to help researchers understand the impact different diseases have on the human heart . Using these technologies, experts get insights into the impact drugs may have on the heart. Novoheart is planning further research .
Biotech company Novoheart has created the world ’s first miniature artificial heart using stem cells , with the goal of offering pharmaceutical testing methods which are more efficient than animal models and clinical trials . The company said its “ heart in a miniature ” saves costs and time . The device replicates one of the human heart ’s four chambers but does not need a blood supply . At the same time , its MyHeart platform offers technology to help researchers understand the impact different diseases have on the human heart . Novoheart is planning further research .